• Guideline Summary
  • NGC:010348
  • 2014 Apr

Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer.

  • Guideline Summary
  • NGC:010540
  • 2013 Aug

EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer.

  • Guideline Summary
  • NGC:010879
  • 2015 Dec 16

Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy.

  • Guideline Summary
  • NGC:010261
  • 2011 Jun (revised 2013 Nov)

Non-small cell lung cancer stage IV.

  • Guideline Summary
  • NGC:009821
  • 2013 Apr 1

Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.

Management of lung cancer. A national clinical guideline.

  • Guideline Summary
  • NGC:010809
  • 1997 May (revised 2015 Oct 20)

Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update.

  • Guideline Summary
  • NGC:010179
  • 1999 (revised 2013)

ACR Appropriateness Criteria® induction and adjuvant therapy for N2 non–small-cell lung cancer.

  • Guideline Summary
  • NGC:010834
  • 2015

ACR Appropriateness Criteria® radiologic management of thoracic nodules and masses.

  • Guideline Summary
  • NGC:009318
  • 1996 (revised 2012 Dec 18)

Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.

  • Guideline Summary
  • NGC:009255
  • 1996 (revised 2012)

ACR Appropriateness Criteria® ovarian cancer screening.

  • Guideline Summary
  • NGC:009668
  • 2012

ACR Appropriateness Criteria® pulmonary hypertension. [Update Pending]

  • Guideline Summary
  • NGC:010502
  • 2014 Jun

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.

  • Guideline Summary
  • NGC:010177
  • 2013

ACR Appropriateness Criteria® thyroid carcinoma.